Antiviral medicines for Hepatitis C Treatment The landscape of Hepatitis C treatment has transformed in recent years with the development of Direct Acting Antiviral (DAAs). These drugs target specific steps in the virus's life cycle, stopping it from replicating.
Commonly used DAAs include:
Sofosbuvir
Ledipasvir
Velpatasvir
Glecaprevir
Pibrentasvir
These medications are often used in combination, tailored to the patient’s specific virus genotype and liver condition.